Neuriva $8 Million Brain Pill Deal Tossed on 11th Cir. Appeal

An $8 million class settlement with Neuriva manufacturer Reckitt Benckiser LLC was vacated by the Eleventh Circuit Wednesday after the court ruled plaintiffs lacked standing to ask a judge to issue an injunction over the company’s allegedly false brain supplement advertising.

Sidestepping a fairness claim on which a class member originally brought his appeal, the US Court of Appeals for the Eleventh Circuit found a lower court wrongfully barred Reckitt Benckiser and RB Health (US) LLC from using certain terms in its marketing.

“Under longstanding Supreme Court precedent, plaintiffs seeking injunctive relief must establish that they are likely to suffer ...